Update in Urologic Oncology 2026
Comprehensive GU Cancer Care Course
Strengthen your clinical approach to genitourinary malignancies with the
Update in Urologic Oncology 2026. This comprehensive, expert-led video course provides
a practical review of the full spectrum of genitourinary oncology, including prostate cancer,
bladder cancer, kidney cancer, testicular cancer, penile cancer, adrenal tumors, survivorship,
robotic surgery, systemic therapy, advanced imaging, biomarkers, and multidisciplinary cancer care.
Designed for clinicians managing complex GU cancers, the program reviews recent clinical trials,
evolving treatment standards, guideline-based decision-making, new diagnostic tools, surgical techniques,
radiation therapy, immuno-oncology, genomic testing, and systemic treatment strategies.
With approximately 22.75 hours of educational content, this course is ideal for board
preparation, clinical knowledge updates, and improving day-to-day decision-making in urologic oncology practice.
💻 Access: Digital delivery for convenient study and offline viewing
👨⚕️ Who Should Take This Course?
This educational program is designed for:
Urologic Oncologists
Medical Oncologists
Radiation Oncologists
Surgical Oncologists
Urology Fellows and Residents
Oncology Fellows
Advanced Practice Providers involved in GU cancer care
Clinicians preparing for urology or oncology board examinations
📚 Course Overview
The Update in Urologic Oncology 2026 delivers clinically relevant education covering
the diagnosis, staging, treatment, follow-up, and survivorship of patients with genitourinary cancers.
The course includes disease-specific treatment algorithms, current guideline updates, pivotal trial data,
emerging systemic therapies, biomarker-driven care, genomic classifiers, advanced imaging, minimally invasive
surgery, robotic procedures, radiation therapy, and multidisciplinary treatment planning.
Participants will gain practical tools to interpret new evidence and apply it to real-world clinical
workflows across academic, hospital, and community-based oncology practices.
🔬 Key Areas Covered
Prostate Cancer
- Contemporary PSA-based screening
- Risk-adapted prostate cancer screening
- Prostate biopsy techniques and pitfalls
- Genomic classifiers for screening and risk stratification
- Active surveillance
- Robotic-assisted radical prostatectomy
- Focal therapy
- Radiation therapy for low-, intermediate-, and high-risk disease
- Oligometastatic prostate cancer
- Biochemical recurrence
- Advanced and metastatic prostate cancer
- Sexual health and treatment-related complications
- Erectile dysfunction and urinary incontinence
- Prostate cancer survivorship
Bladder and Urothelial Cancer
- Microscopic and gross hematuria evaluation
- Non-muscle-invasive bladder cancer
- Risk stratification and treatment
- Muscle-invasive bladder cancer
- Neoadjuvant chemotherapy
- Adjuvant systemic therapy
- Radical cystectomy
- Urinary diversion
- Trimodality bladder-preservation protocols
- Upper-tract urothelial carcinoma
- Sexual health after radical cystectomy
Kidney and Renal Cell Carcinoma
- Renal mass detection and staging
- Advanced imaging strategies
- Management of small renal masses
- Open and robotic surgical approaches
- Cytoreductive nephrectomy
- Venous tumor thrombi
- Radiation therapy in renal cell carcinoma
- Systemic therapy for advanced RCC
- Non-clear-cell renal cancers
- Hereditary RCC syndromes
Testicular and Germ-Cell Tumors
- Early-stage germ-cell tumors
- Metastatic germ-cell cancer
- Surgical and systemic treatment strategies
- Long-term management and survivorship
Penile Cancer
- Organ-confined penile cancer
- Locally advanced and metastatic disease
- Surgical and multidisciplinary treatment planning
Adrenal Tumors
- Diagnosis and management of benign adrenal lesions
- Evaluation of malignant adrenal masses
- Surgical considerations for urologists
🚀 Emerging and Multidisciplinary Topics
Clinical trial interpretation
Epidemiology and global burden of GU malignancies
Frailty assessment
Enhanced recovery after surgery
Palliative and end-of-life care
Smoking cessation
Pediatric urologic oncology
Robotic surgery performance and efficiency
Value-based and patient-centered cancer care
🎯 Learning Objectives
After completing this activity, learners should be able to:
- Interpret recent NCCN and AUA guideline updates and pivotal clinical trial data.
- Optimize the management of localized, recurrent, and advanced genitourinary cancers.
- Integrate imaging, genomic, molecular, and biomarker information into personalized treatment plans.
- Develop multidisciplinary strategies that appropriately sequence surgery, systemic therapy, radiation therapy, and survivorship care.
- Apply evidence-based approaches to improve care coordination and patient outcomes.
- Evaluate emerging therapies and evolving standards of care in GU oncology.
- Incorporate patient preferences, quality-of-life considerations, and survivorship goals into clinical decision-making.
- Translate new research findings into practical clinical workflows.
📋 Complete Topics
⭐ Why Choose This Course?
- Comprehensive coverage of all major genitourinary cancers
- Approximately 22.75 hours of expert-led education
- Video lectures and PDF materials included
- Latest treatment approaches and clinical trial updates
- Board-relevant review of prostate, bladder, kidney, testicular, penile, and adrenal cancers
- Practical guidance for multidisciplinary cancer care
- Valuable for both board preparation and clinical practice
Reviews
There are no reviews yet.